Add BrightSurf on Google Email

Science News Archive 2006 - Page 31


Page 31 of 178

Study reveals religious leader's silent secret

A University of Alberta researcher found that John de Ruiter's silent approach asserts his charismatic authority over followers by projecting their own meaning, discouraging dissent, and forming intimate bonds. This method allows de Ruiter to continually prove himself as extraordinary to his followers.

SourceUniversity of Alberta·JournalJournal of Contemporary Religion·DateOct 30, 2006

First evidence to show elephants, like humans, apes and dolphins, recognize themselves in mirror

Researchers at Emory University's Yerkes National Primate Research Center found that elephants can recognize themselves in a mirror, exhibiting complex behaviors like self-awareness and social complexity. This discovery suggests convergent evolution with humans and highlights the species' high level of intelligence and empathy.

SourceEmory University Health Sciences Center·JournalProceedings of the National Academy of Sciences·DateOct 30, 2006

Tastes great! Study shows brain's response to pleasing -- and changing -- tastes

Researchers tracked brain activity in rats while they tasted water, salt water, and sugar water, finding that a formerly disliked taste became pleasurable when the rats were deprived of salt. This study provides new insights into how the brain processes pleasure and has implications for understanding eating disorders and addiction.

SourceMichigan Medicine - University of Michigan·JournalJournal of Neurophysiology·DateOct 30, 2006

Turmeric prevents experimental rheumatoid arthritis, bone loss, University of Arizona study shows

A new study by researchers at the University of Arizona found that turmeric extract can prevent experimental rheumatoid arthritis and reduce bone loss. The curcuminoid extract inhibited the activation of NF-KB, a protein that enhances production of inflammatory proteins, and blocked the pathway that affects bone resorption.

SourceUniversity of Arizona Health Sciences·JournalArthritis & Rheumatism·DateOct 30, 2006

Towards predicting late-stage radiation toxicity

Researchers identified a gene expression profile associated with late radiation toxicity, correctly classifying 63% of patient populations. The study suggests that some patients are genetically predisposed to develop late-radiation toxicity and provides clues about molecular pathways involved.

SourcePLOS·JournalPLOS Medicine·DateOct 30, 2006

Connection between depression and osteoporosis shown by Hebrew University researchers

Researchers at Hebrew University found a link between depression and osteoporosis, showing that anti-depressant drugs can halt bone density loss. The study used laboratory mice to demonstrate the connection, revealing a neural system linking the brain to bones, which is disrupted in depressed individuals.

SourceThe Hebrew University of Jerusalem·JournalProceedings of the National Academy of Sciences·DateOct 30, 2006

Osteoarthritis patients treated with acupuncture show improvement

A randomized controlled trial found that osteoarthritis patients who received acupuncture treatment in addition to routine care showed significant improvements in symptoms and quality of life. The study's results suggest that acupuncture can be an effective treatment option for OA patients, with benefits lasting beyond the therapy period.

SourceWiley·JournalArthritis & Rheumatism·DateOct 30, 2006

The power behind insect flight: Researchers reveal key kinetic component

Researchers have discovered a key molecular mechanism allowing tiny flies to whirl their wings at high speeds, revealing new insights into heart disease and the evolution of flight. The findings provide a better understanding of how chemical energy is converted into muscle movements, including human heart muscle pumping blood.

SourceRensselaer Polytechnic Institute·JournalProceedings of the National Academy of Sciences·DateOct 30, 2006

Faulty gene linked to prostate cancer risk

A large germline deletion in the Chek2 kinase gene is associated with an almost doubled risk of prostate cancer. The study found this deletion in 24% of healthy people and 0.8% of diagnosed patients from Poland, suggesting a higher prevalence among men from eastern Europe.

SourceBMJ Specialty Journals·JournalJournal of Medical Genetics·DateOct 30, 2006

MRSA vaccine shows promise in mouse study

Researchers at the University of Chicago have developed a vaccine that protects mice against multiple, drug-resistant strains of Staphylococcus aureus. The combined vaccine, based on four bacterial surface proteins, provided significant protection against five virulent strains and reduced bacterial load to undetectable levels.

SourceUniversity of Chicago Medical Center·JournalProceedings of the National Academy of Sciences·DateOct 30, 2006

A Wellcome brain gain for world leading neuroscience lab

The Wellcome Trust Centre for Neuroimaging at UCL will further bolster the reputation of a laboratory renowned for its research into neural cognition and common neurological diseases. The centre aims to study the functional architecture of the human brain to identify core mechanisms causing common human neurological diseases.

Looking to a new era in bee research

The honey bee genome sequencing project has generated exciting results, providing new insights into diverse topics in honey bee biology, including neurobiology and caste determination. The project's findings have also shed light on disease-resistant pathways and metabolic adaptations to an all-floral diet.

SourceBlackwell Publishing Ltd.·JournalInsect Molecular Biology·DateOct 27, 2006

Laurie Garrett on health workers sentenced to die in Libya

The imminent executions of six foreign health workers in Libya will have severe repercussions for the global healthcare community. The case has garnered widespread criticism from the scientific and medical fields, highlighting the importance of protecting healthcare workers' rights.

SourcePLOS·JournalPLOS Medicine·DateOct 27, 2006

New insight into cell division

Researchers at Max Planck Institute for Molecular Genetics in Berlin have explained the molecular principles of cell division control mechanisms. The study found that checkpoint kinases interact with a different category of proteins involved in developing the cell division spindle.

SourceMax-Planck-Gesellschaft·JournalScience·DateOct 27, 2006

Saving salivary glands from the collateral damage of radiation therapy

Targeted overexpression of HSP25 protects salivary gland function by maintaining gland weight, salivary flow rate, and salivary fluid composition. HSP25 also preserves expression of aquaporin 5, crucial for water transport in salivary glands. These findings suggest a novel radioprotective strategy against radiation-induced salivary gla...

SourceAmerican Journal of Pathology·JournalAmerican Journal Of Pathology·DateOct 27, 2006

UC Davis scientists' groundbreaking research: Mate-attracting chemicals

Researchers at UC Davis have successfully engineered fruit flies to respond to the scent of silkworm moths, a breakthrough that could lead to designing better chemicals to attract insects. The findings have important implications for agricultural pest control and medical entomology, with potential applications in suppressing insect com...

SourceUniversity of California - Davis·JournalProceedings of the National Academy of Sciences·DateOct 27, 2006

Prominent hypertension specialists question results of TROPHY study on hypertension

Two editorials in the American Journal of Hypertension argue that the TROPHY study is flawed due to its unusual definition of incident hypertension. The studies caution that the treatment may not be effective in preventing the development of hypertension, and instead suggest that it could cause a slow unmasking of high blood pressure.

SourceElsevier Health Sciences·JournalAmerican Journal of Hypertension·DateOct 27, 2006

New cancer drug hope

Researchers at the University of Manchester have made a breakthrough in developing a new class of cancer drugs that target the Aurora B enzyme, which helps cells divide and can lead to uncontrolled cell growth in cancer. Early clinical trials suggest the drug's toxicity is mild, offering a revolutionary new way to treat cancer.

SourceUniversity of Manchester·JournalJournal of Cell Science·DateOct 26, 2006